Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 408
Selected: 0
NCT IDTitle
NCT01770301Efficacy and Safety of Bevacizumab (Avastin®) Combined to Weekly Paclitaxel Followed by Bevacizumab (Avastin®) Alone in Patients With Relapsed Ovarian Sex-cord Stromal Tumours (ALIENOR)
NCT00901524ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIV
NCT03915678Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors
NCT00275535The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients
NCT03301493Genomic Testing and Resulting Medical Decisions
NCT01249638Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC
NCT01303887A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients
NCT04484636PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)
NCT00453362A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib
NCT00177255A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers
NCT02776566Patient-Centered Anticoagulation Self-Monitoring in Minority Patients
NCT01188707A Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung Cancer
NCT01752192Teledi@Log - Tele-rehabilitation of Heart Patients
NCT03163732Evaluation of the Added Value of a Large Molecular Profiling Panel Versus a Limited Molecular Profiling Panel in Advanced Solid Tumors.
NCT01828736Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma
NCT01326559Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)
NCT01172392A Randomized Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis B
NCT04490044Under and Over Rehabilitation Study
NCT00485589A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate (FILM)
NCT01076023Cohort Study in Type 2 Diabetes in China
NCT01633346Regulation of the Immune System in Response to the Treatment With Tocilizumab in Rheumatoid Arthritis Patients
NCT01259856Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)
NCT02636452Cardiopulmonary Exercise Testing in Interstitial Lung Disease
NCT03340376Doxorubicin Alone Versus Atezolizumab Alone Versus Doxorubicin and Atezolizumab in Recurrent Cervical Cancer
NCT01428414Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer
NCT00363116A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients
NCT05525858KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II
NCT00074438Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid Arthritis
NCT00275132Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
NCT03961698Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma
NCT02569736Characterization of the Effect of Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in Rheumatoid Arthritis Patients and Consequence on B Cells Maturation
NCT03147040AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer
NCT05529524Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)
NCT00952003Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients
NCT01660776BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology
NCT04993274Sensitivity of Motor Assessment in MS - a Prospective Cohort Study
NCT00842114Rituximab and CVP Plus Interferon for Follicular Non Hodgkins Lymphoma (NHL)
NCT02738580Follicular Steroid Genesis in Controlled Ovarian Stimulation
NCT00626197A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG)
NCT00784446First-line Therapy of Stage IV Colorectal Cancer
NCT02914470Carboplatin-cyclophosphamide Combined With Atezolizumab
NCT05825261Exploring Novel Biomarkers for Emphysema Detection
NCT01066689Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation
NCT06008691A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice
NCT00973609Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC)
NCT00957866Prospective Anti-Hepatitis C Virus (Anti-HCV) Trial of Peg-Interferon and Ribavirin in Subjects of First Nations, Metis and Caucasian Ethnicity
NCT00205556Effect of Increased Convective Clearance by On-Line Hemodiafiltration on All Cause Mortality in Chronic Hemodialysis Patients
NCT01729481Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic Cancer
NCT01126866Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy
NCT02790645Telemedicine Program in Type 1 Diabetes and CSII